CX3CL1 and COVID-19: Increased levels of cerebrospinal fluid chemokines, including CX3CL1, might facilitate the trafficking of monocytes to the cerebrospinal fluid, and potentially contribute to the development of neurological symptoms in patients with COVID-19 [90].